T cell immunity and graft-versus-host disease (GVHD)

Dickinson, 2002, In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens, Nat Med, 8, 410, 10.1038/nm0402-410 Norton, 1992, Adhesion molecule expression in human hepatic graft-versus-host disease, Bone Marrow Transplant, 10, 153 Goker, 2001, Acute graft-vs-host disease: pathobiology and management, Exp Hematol, 29, 259, 10.1016/S0301-472X(00)00677-9 Kataoka, 2001, The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease, Immunology, 103, 310, 10.1046/j.1365-2567.2001.01240.x Joffre, 2004, Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes, Blood, 103, 4216, 10.1182/blood-2004-01-0005 Hoffmann, 2002, Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation, J Exp Med, 196, 389, 10.1084/jem.20020399 Edinger, 2003, CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation, Nat Med, 9, 1144, 10.1038/nm915 Simpson, 2002, Minor H antigens: genes and peptides, Transpl Immunol, 10, 115, 10.1016/S0966-3274(02)00057-6 Jones, 2004, Specific donor Vβ-associated CD4+ T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens, Biol Blood Marrow Transplant, 10, 91, 10.1016/j.bbmt.2003.10.002 Miconnet, 1998, Relative importance of CD4+ and CD8+ T cell repertoires in the development of acute graft-versus-host disease in a murine model of bone marrow transplantation, Bone Marrow Transplant, 21, 583, 10.1038/sj.bmt.1701136 Murata, 2003, A human minor histocompatibility antigen resulting from differential expression due to a gene deletion, J Exp Med, 197, 1279, 10.1084/jem.20030044 Friedman, 2001, Vβ spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate, Biol Blood Marrow Transplant, 7, 2, 10.1053/bbmt.2001.v7.pm11215694 Hirokawa, 2002, Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation, Bone Marrow Transplant, 30, 915, 10.1038/sj.bmt.1703730 Bruley Rosset, 2003, Differences in MHC-class I presented minor histocompatibility antigens extracted from normal and graft-versus-host disease (GVHD) mice, Clin Exp Immunol, 132, 46, 10.1046/j.1365-2249.2003.02115.x Yu, 2000, CD28-specific antibody prevents graft-versus-host disease in mice, J Immunol, 164, 4564, 10.4049/jimmunol.164.9.4564 Yu, 2004, CD28 ligation induces transplantation tolerance by IFN-γ-dependent depletion of T cells that recognize alloantigens, J Clin Invest, 113, 1624, 10.1172/JCI200420940 Duffner, 2004, Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease, J Immunol, 172, 7393, 10.4049/jimmunol.172.12.7393 Merad, 2004, Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease, Nat Med, 10, 510, 10.1038/nm1038 Jones, 2003, Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model, J Clin Invest, 112, 1880, 10.1172/JCI19427 Shlomchik, 1999, Prevention of graft versus host disease by inactivation of host antigen-presenting cells, Science, 285, 412, 10.1126/science.285.5426.412 Teshima, 2002, Acute graft-versus-host disease does not require alloantigen expression on host epithelium, Nat Med, 8, 575, 10.1038/nm0602-575 Welniak, 2000, Opposing roles of interferon-γ on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning, Biol Blood Marrow Transplant, 6, 604, 10.1016/S1083-8791(00)70025-5 MacDonald, 2004, Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation, Biol Blood Marrow Transplant, 10, 373, 10.1016/j.bbmt.2004.02.002 Nikolic, 2000, Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets, J Clin Invest, 105, 1289, 10.1172/JCI7894 New, 2002, T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease, Bone Marrow Transplant, 29, 979, 10.1038/sj.bmt.1703563 Serody, 2000, T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease, Blood, 96, 2973, 10.1182/blood.V96.9.2973 Welniak, 2004, An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease, Exp Hematol, 32, 318, 10.1016/j.exphem.2003.12.003 Murai, 1999, Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease, J Clin Invest, 104, 49, 10.1172/JCI6642 Wysocki, 2004, Differential roles for CCR5 expression on donor T Cells during graft-versus-host disease based on pretransplant conditioning, J Immunol, 173, 845, 10.4049/jimmunol.173.2.845 Duffner, 2003, Role of CXCR3-induced donor T-cell migration in acute GVHD, Exp Hematol, 31, 897, 10.1016/S0301-472X(03)00198-X Miwa, 1999, Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease, Int Immunol, 11, 925, 10.1093/intimm/11.6.925 Jiang, 2001, Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesis, Blood, 98, 390, 10.1182/blood.V98.2.390 Marks, 2004, Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients, Transplantation, 77, 804, 10.1097/01.TP.0000110416.96307.D5 Ueno, 2000, Fas-mediated cholangiopathy in the murine model of graft versus host disease, Hepatology, 31, 966, 10.1053/he.2000.5764 Hattori, 1998, Differential effects of anti-Fas ligand and anti-tumor necrosis factor a antibodies on acute graft-versus-host disease pathologies, Blood, 91, 4051, 10.1182/blood.V91.11.4051 van den Brink, 2000, Fas-deficient lpr mice are more susceptible to graft-versus-host disease, J Immunol, 164, 469, 10.4049/jimmunol.164.1.469 Schmaltz, 2003, Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation, Blood, 101, 2440, 10.1182/blood-2002-07-2109 Ichiba, 2003, Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays, Blood, 102, 763, 10.1182/blood-2002-09-2748 Panoskaltsis-Mortari, 2001, Intercellular adhesion molecule-I (ICAM-I, CD54) deficiency segregates the unique pathophysiological requirements for generating idiopathic pneumonia syndrome (IPS) versus graft-versus-host disease following allogeneic murine bone marrow transplantation, Biol Blood Marrow Transplant, 7, 368, 10.1053/bbmt.2001.v7.pm11529486